DAVID
NAVARRO ORTEGA
CATEDRÁTICO/A DE UNIVERSIDAD
Hospital Universitario Pío del Río Hortega
Valladolid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Pío del Río Hortega (9)
2023
-
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
Scientific Reports, Vol. 13, Núm. 1
-
Sample Treatment with Trypsin for RT-LAMP COVID-19 Diagnosis
Biology, Vol. 12, Núm. 7
2019
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
2017
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
-
Human T-lymphotropic virus type 1 infection and disease in Spain
AIDS, Vol. 31, Núm. 12, pp. 1653-1663
2014
-
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194
2012
-
Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1181-1187
2011
-
Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: Results from the FUNGEMYCA study.
Revista Iberoamericana de Micologia, Vol. 28, Núm. 2, pp. 91-99
-
Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia
Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 12, pp. 5590-5596